High-dose therapy in patients with Hodgkin's disease: the use of selected CD34(+) cells is as safe as unmanipulated peripheral blood progenitor cells (Q43848130)
Jump to navigation
Jump to search
scientific article published in November 2001
Language | Label | Description | Also known as |
---|---|---|---|
English | High-dose therapy in patients with Hodgkin's disease: the use of selected CD34(+) cells is as safe as unmanipulated peripheral blood progenitor cells |
scientific article published in November 2001 |
Statements
1 reference
High-dose therapy in patients with Hodgkin's disease: the use of selected CD34(+) cells is as safe as unmanipulated peripheral blood progenitor cells (English)
1 reference
1 reference
Smeland E
1 reference
Holte H
1 reference
Kvalheim G
1 reference
Blystad AK
1 reference
Kvaløy S
1 reference
1 November 2001
1 reference
1 reference
28
1 reference
9
1 reference
849-857
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference